<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03556748</url>
  </required_header>
  <id_info>
    <org_study_id>EMS Nutr hemato onko</org_study_id>
    <nct_id>NCT03556748</nct_id>
  </id_info>
  <brief_title>WB-EMS and Nutrition in Patients With Hematological Malignancies</brief_title>
  <official_title>Effect of Whole-body Electromyostimulation Combined With Individualized Nutritional Support on Patients With Hematological Malignancies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Erlangen-Nürnberg Medical School</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Erlangen-Nürnberg Medical School</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the effects of a whole-body electromyostimulation (WB-EMS) training
      combined with individualized nutritional support on skeletal muscle mass, body composition,
      muscle strength/function, quality of life, fatigue, pain and gastrointestinal symptoms in
      patients with hematological malignancies 4-6 weeks before and 4-6 weeks after undergoing stem
      cell Transplantation. Within this context, this study also investigates the effect of the
      nutrition and exercise intervention on the period of hospitalization, period of White blood
      cell recovery and frequency and severity of complications (mucositis,
      Graft-versus-Host-Disease, infections) after stem cell Transplantation as consequences of the
      therapeutic immune Suppression.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">November 1, 2017</start_date>
  <completion_date type="Anticipated">October 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>WB-EMS training is performed 2x/week for 12 weeks; Stimulation protocol: Frequency of 85 Hz, pulse duration of 0.35 ms, stimulation period of 6 sec, resting period of 4 sec; supervised by certified training instructors/physiotherapists participants perform simple exercises during the stimulation period following a video tutorial</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Skeletal muscle mass</measure>
    <time_frame>12 weeks</time_frame>
    <description>Skeletal muscle mass assessed by bioelectrical impedance analysis (in kg)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Physical function - Isometric muscle strength</measure>
    <time_frame>12 weeks</time_frame>
    <description>Hand grip strength assessed by hand dynamometer (in kg)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiorespiratory Fitness</measure>
    <time_frame>12 weeks</time_frame>
    <description>VO2max assessed by spirometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient-reported Quality of Life (QoL)</measure>
    <time_frame>12 weeks</time_frame>
    <description>EORTC QLQ - C30 questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient-reported Fatigue</measure>
    <time_frame>12 weeks</time_frame>
    <description>FACIT-Fatigue scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression/Anxiety</measure>
    <time_frame>12 weeks</time_frame>
    <description>Hospital Anxiety and Depression Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inflammatory blood markers</measure>
    <time_frame>12 weeks</time_frame>
    <description>Blood collection and analysis (Albumin, CRP, Cytokines)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Hematologic Diseases</condition>
  <condition>Cachexia; Cancer</condition>
  <condition>Leukemia</condition>
  <condition>Myeloma</condition>
  <condition>Lymphoma</condition>
  <condition>Cancer</condition>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>usual care&quot; control group receives individualized nutritional support (dietary advices: daily protein intake 1.2-1.5 g/kg bodyweight),
active exercise therapy is optionally provided (bicycle ergometers at room) during the in-Patient stay</description>
  </arm_group>
  <arm_group>
    <arm_group_label>WB-EMS group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>physical exercise group regular WB-EMS training (2 EMS trainings per week; each session for 20 min)
+ individualized nutritional support (dietary advices: daily protein intake 1.2-1.5 g/kg bodyweight)
active exercise therapy is optionally provided (bicycle ergometers at room) during the in-Patient stay</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>whole-body electromyostimulation</intervention_name>
    <description>WB-EMS training is performed 2x/week for a total of 12 weeks; Stimulation protocol: Frequency of 85 Hz, pulse duration of 0.35 ms, stimulation period of 6 sec, resting period of 4 sec; supervised by certified training instructors/physiotherapists participants perform simple exercises during the stimulation period following a video tutorial</description>
    <arm_group_label>WB-EMS group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adult patients diagnosed with hematological malignancies with an indication for stem
             cell Transplantation

          -  Interval until Transplantation: 6 weeks

          -  ECOG Status 0-2

        Exclusion Criteria:

          -  patients with serious osteolytic lesions and increased risk of fall

          -  simultaneous participation in other nutritional or exercise intervention Trials or in
             the past 6 months

          -  acute cardiovascular events

          -  use of anabolic medications

          -  epilepsy

          -  severe neurological diseases

          -  skin lesions in the area of electrodes

          -  energy active metals in body

          -  acute vein thrombosis

          -  rheumatic diseases

          -  pregnant and nursing women

          -  psychiatric disorders with doubts about legal and cognitive capacity
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Medicine 1, Hector Center for Nutrition, Exercise and Sports, Friedrich-Alexander-University Erlangen-Nuremberg</name>
      <address>
        <city>Erlangen</city>
        <zip>91052</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yurdaguel Zopf, Prof. Dr. med.</last_name>
      <phone>+49 9131 85-45218</phone>
      <email>yurdaguel.zopf@uk-erlangen.de</email>
    </contact>
    <contact_backup>
      <last_name>Hans Joachim Herrmann, Dr. oec. troph.</last_name>
      <phone>+49 9131 85-45017</phone>
      <email>hans.herrmann@uk-erlangen.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>June 2018</verification_date>
  <study_first_submitted>June 4, 2018</study_first_submitted>
  <study_first_submitted_qc>June 4, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 14, 2018</study_first_posted>
  <last_update_submitted>June 4, 2018</last_update_submitted>
  <last_update_submitted_qc>June 4, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">June 14, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>hematological malignancies</keyword>
  <keyword>leukemia</keyword>
  <keyword>myeloma</keyword>
  <keyword>lymphoma</keyword>
  <keyword>exercise</keyword>
  <keyword>nutrition</keyword>
  <keyword>protein</keyword>
  <keyword>WB-EMS</keyword>
  <keyword>whole-body electromyostimulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hematologic Neoplasms</mesh_term>
    <mesh_term>Hematologic Diseases</mesh_term>
    <mesh_term>Cachexia</mesh_term>
    <mesh_term>Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

